<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38771409</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1568-5608</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Inflammopharmacology</Title><ISOAbbreviation>Inflammopharmacology</ISOAbbreviation></Journal><ArticleTitle>Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols.</ArticleTitle><Pagination><StartPage>2075</StartPage><EndPage>2090</EndPage><MedlinePgn>2075-2090</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10787-024-01483-2</ELocationID><Abstract><AbstractText>Long COVID, now unmistakably identified as a syndromic entity encompassing a complex spectrum of symptoms, demands immediate resolution of its elusive pathogenic underpinnings. The intricate interplay of diverse factors presents a complex puzzle, difficult to resolve, and thus poses a substantial challenge. As instances of long COVID manifest by repeated infections of SARS-CoV-2 and genetic predisposition, a detailed understanding in this regard is needed. This endeavor is a comprehensive exploration and analysis of the cascading pathogenetic events driven by viral persistence and replication. Beyond its morbidity, long COVID, more disabling than fatal, exacts one of the most substantial tolls on public health in contemporary times, with the potential to cripple national economies. The paper introduces a unified theory of long COVID, detailing a novel pathophysiological framework that interlinks persistent SARS-CoV-2 infection, autoimmunity, and systemic vascular pathology. We posit a model where viral reservoirs, immune dysregulation, and genetic predispositions converge to perpetuate disease. It challenges prevailing hypotheses with new evidence, suggesting innovative diagnostic and therapeutic approaches. The paper aims to shift the paradigm in long COVID research by providing an integrative perspective that encapsulates the multifaceted nature of the condition. We explain the immunological mechanisms, hypercoagulability states, and viral reservoirs in the skull that feed NeuroCOVID in patients with long COVID. Also, this study hints toward a patient approach and how to prioritize treatment sequences in long COVID patients in hospitals and clinics.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Baig</LastName><ForeName>Abdul Mannan</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-0626-216X</Identifier><AffiliationInfo><Affiliation>Clinicum St. George, Rosenheimer Str. 6-8, Bad Aibling, Germany. AbdulMannan.Baig@clinicum-stgeorg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosko</LastName><ForeName>Sandy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinicum St. George, Rosenheimer Str. 6-8, Bad Aibling, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jaeger</LastName><ForeName>Beate</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinicum St. George, Rosenheimer Str. 6-8, Bad Aibling, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerlach</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinicum St. George, Rosenheimer Str. 6-8, Bad Aibling, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rausch</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinicum St. George, Rosenheimer Str. 6-8, Bad Aibling, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Inflammopharmacology</MedlineTA><NlmUniqueID>9112626</NlmUniqueID><ISSNLinking>0925-4692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Multi-System Inflammation</Keyword><Keyword MajorTopicYN="N">NeuroCOVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Spike Protein</Keyword><Keyword MajorTopicYN="N">Viral Persistence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>5</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>21</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>21</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38771409</ArticleId><ArticleId IdType="doi">10.1007/s10787-024-01483-2</ArticleId><ArticleId IdType="pii">10.1007/s10787-024-01483-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L (2020) The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res 194:101&#x2013;115. https://doi.org/10.1016/j.thromres.2020.06.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.06.029</ArticleId><ArticleId IdType="pubmed">32788101</ArticleId><ArticleId IdType="pmc">7305763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ankerhold J, Giese S, Kolb P, Maul-Pavicic A, Voll RE, G&#xf6;ppert N, Ciminski K, Kreutz C, Lother A, Salzer U, Bildl W, Welsink T, Morgenthaler NG, Grawitz AB, Emmerich F, Steinmann D, Huzly D, Schwemmle M, Hengel H, Falcone V (2022) Circulating multimeric immune complexes contribute to immunopathology in COVID-19. Nat Commun 13(1):5654. https://doi.org/10.1038/s41467-022-32867-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32867-z</ArticleId><ArticleId IdType="pubmed">36163132</ArticleId><ArticleId IdType="pmc">9513013</ArticleId></ArticleIdList></Reference><Reference><Citation>Arish M, Qian W, Narasimhan H, Sun J (2023) COVID-19 immunopathology: from acute diseases to chronic sequelae. J Med Virol 95(1):e28122. https://doi.org/10.1002/jmv.28122</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28122</ArticleId><ArticleId IdType="pubmed">36056655</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, Lim PB, McNarry M, Morten K, O&#x2019;Sullivan O, Pretorius E, Raman B, Soteropoulos DS, Taquet M, Hall CN (2023) Long COVID: mechanisms, risk factors and recovery. Exp Physiol 108(1):12&#x2013;27. https://doi.org/10.1113/EP090802</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo EP, Guimar&#xe3;es-Costa AB, Torezani GS, Braga CA, Palhano FL, Kelly JW, Saraiva EM, Foguel D (2012) Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase. J Biol Chem 287(44):37206&#x2013;37218. https://doi.org/10.1074/jbc.M112.369942</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.369942</ArticleId><ArticleId IdType="pubmed">22918834</ArticleId><ArticleId IdType="pmc">3481320</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM (2020) Deleterious outcomes in Long-Hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci 11(24):4017&#x2013;4020. https://doi.org/10.1021/acschemneuro.0c00725</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00725</ArticleId><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Gerlach J (2023) Intranasal route: a nasocerebral approach against SARS-CoV-2 in NeuroCOVID. ACS Chem Neurosci 14(19):3560&#x2013;3563. https://doi.org/10.1021/acschemneuro.3c00488</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.3c00488</ArticleId><ArticleId IdType="pubmed">37698524</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11(7):995&#x2013;998. https://doi.org/10.1021/acschemneuro.0c00122</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett KE, Barman SM, Brooks HL, Yuan JJ (2019) [publicationyear2] Ganong's review of medical physiology, 26e. McGraw-Hill Education. (accessed on 22-March-2024) . Accessed 22 March 2024</Citation></Reference><Reference><Citation>Boldogh I, Albrecht T, Porter DD (1996) Persistent viral infections. In: Baron S (ed) Medical Microbiology, 4th edn. University of Texas Med Branch, Galveston</Citation></Reference><Reference><Citation>Bowe B, Xie Y, Xu E, Al-Aly Z (2021) Kidney outcomes in Long COVID. J Am Soc Nephrol 32(11):2851&#x2013;2862. https://doi.org/10.1681/ASN.2021060734</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId><ArticleId IdType="pmc">8806085</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown WR (1978) Relationships between immunoglobulins and the intestinal epithelium. Gastroenterology 75(1):129&#x2013;138</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0016-5085(78)93779-4</ArticleId><ArticleId IdType="pubmed">401401</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Martino L, Morello R, Mariani F, Fearnley K, Valentini P (2023) Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies. Lancet Microbe 4(9):e745&#x2013;e756. https://doi.org/10.1016/S2666-5247(23)00115-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00115-5</ArticleId><ArticleId IdType="pubmed">37385286</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt A, Erkan D, Lee AI (2022) COVID-19 and antiphospholipid antibodies. Best Pract Res Clin Haematol 35(3):101402. https://doi.org/10.1016/j.beha.2022.101402</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beha.2022.101402</ArticleId><ArticleId IdType="pubmed">36494152</ArticleId><ArticleId IdType="pmc">9568270</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan AJ, Wiffen LJ, Brown TP (2020) COVID-19: a collision of complement, coagulation and inflammatory pathways. J Thromb Haemost&#x202f;: JTH 18(9):2110&#x2013;2117. https://doi.org/10.1111/jth.14981</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14981</ArticleId><ArticleId IdType="pubmed">32608159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB, Mechanistic Pathways Task Force R (2023) Viral persistence, reactivation, and mechanisms of long COVID. Elife 12:e86015. https://doi.org/10.7554/eLife.86015</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId><ArticleId IdType="pmc">10159620</ArticleId></ArticleIdList></Reference><Reference><Citation>Chippa V, Aleem A, Anjum F (2023) Post-acute coronavirus (COVID-19) syndrome. StatPearls Publishing, In StatPearls</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133&#x2013;146. https://doi.org/10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Dizaji Asl K, Mazloumi Z, Majidi G, Kalarestaghi H, Sabetkam S, Rafat A (2022) NK cell dysfunction is linked with disease severity in SARS-CoV-2 patients. Cell Biochem Funct 40(6):559&#x2013;568. https://doi.org/10.1002/cbf.3725</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.3725</ArticleId><ArticleId IdType="pubmed">35833321</ArticleId><ArticleId IdType="pmc">9350078</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, Jbabdi S, Taschler B, Keating P, Winkler AM, Collins R, Matthews PM, Allen N, Miller KL, Nichols TE, Smith SM (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604(7907):697&#x2013;707. https://doi.org/10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId><ArticleId IdType="pmc">9046077</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshafie A, Foda E, Yousef MMG, El-Naby KAA (2023) Evaluation of protein C and S levels in patients with COVID-19 infection and their relation to disease severity. Egypt J Intern Med 35(1):14. https://doi.org/10.1186/s43162-023-00195-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43162-023-00195-3</ArticleId><ArticleId IdType="pubmed">36845330</ArticleId><ArticleId IdType="pmc">9940684</ArticleId></ArticleIdList></Reference><Reference><Citation>Forstag EH, Denning LA (2022)&#xa0;National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services. Long COVID: examining long-term health effects of covid-19 and implications for the social security administration: proceedings of a workshop. National Acad Press (US)</Citation></Reference><Reference><Citation>Gerber GF, Chaturvedi S (2021) How to recognize and manage COVID-19-associated coagulopathy. Hematol Am Soc Hematol Educ Program 2021(1):614&#x2013;620. https://doi.org/10.1182/hematology.2021000297</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/hematology.2021000297</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach J, Baig AM, Fabrowski M, Viduto V (2023) The immune paradox of SARS-CoV-2: lymphocytopenia and autoimmunity evoking features in COVID-19 and possible treatment modalities. Rev Med Virol 33(2):e2423. https://doi.org/10.1002/rmv.2423</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2423</ArticleId><ArticleId IdType="pubmed">36727514</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Patibandla S (2023) Protein C deficiency. StatPearls Publ, In StatPearls</Citation></Reference><Reference><Citation>Guzman-Esquivel J, Mendoza-Hernandez MA, Guzman-Solorzano HP, Sarmiento-Hernandez KA, Rodriguez-Sanchez IP, Martinez-Fierro ML, Paz-Michel BA, Murillo-Zamora E, Rojas-Larios F, Lugo-Trampe A, Plata-Florenzano JE, Delgado-Machuca M, Delgado-Enciso I (2023) Clinical characteristics in the acute phase of COVID-19 that predict long COVID: tachycardia, myalgias, severity, and use of antibiotics as main risk factors, while education and blood group b are protective. Healthcare (basel, Switzerland) 11(2):197. https://doi.org/10.3390/healthcare11020197</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11020197</ArticleId><ArticleId IdType="pubmed">36673565</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad NS, Nguyen DC, Kuruvilla ME, Morrison-Porter A, Anam F, Cashman KS, Ramonell RP, Kyu S, Saini AS, Cabrera-Mora M, Derrico A, Alter D, Roback JD, Horwath M, O&#x2019;Keefe JB, Wu HM, Ian Wong AK, Dretler AW, Gripaldo R, Lane AN, Eun-Hyung Lee F (2020) Elevated SARS-CoV-2 antibodies distinguish severe disease in early COVID-19 infection. bioRxiv. https://doi.org/10.1101/2020.12.04.410589</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.04.410589</ArticleId><ArticleId IdType="pubmed">33299998</ArticleId><ArticleId IdType="pmc">7724666</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidar MA, Shakkour Z, Reslan MA, Al-Haj N, Chamoun P, Habashy K, Kaafarani H, Shahjouei S, Farran SH, Shaito A, Saba ES, Badran B, Sabra M, Kobeissy F, Bizri M (2022) SARS-CoV-2 involvement in central nervous system tissue damage. Neural Regen Res 17(6):1228&#x2013;1239. https://doi.org/10.4103/1673-5374.327323</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.327323</ArticleId><ArticleId IdType="pubmed">34782556</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashikuni Y, Liu W, Obana T, Sata M (2021) Pathogenic basis of thromboinflammation and endothelial injury in COVID-19: current findings and therapeutic implications. Int J Mol Sci 22(21):12081. https://doi.org/10.3390/ijms222112081</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222112081</ArticleId><ArticleId IdType="pubmed">34769508</ArticleId><ArticleId IdType="pmc">8584434</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeger BR, Arron HE, Kalka-Moll WM, Seidel D (2022) The potential of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.)-apheresis for patients with severe acute or chronic COVID-19. Front Cardiovasc Med 9:1007636. https://doi.org/10.3389/fcvm.2022.1007636</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1007636</ArticleId><ArticleId IdType="pubmed">36304538</ArticleId><ArticleId IdType="pmc">9592739</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchareme J (2022) Tiny blood clots may be to blame for Long COVID symptoms, some researchers say https://time.com/6238147/microclots-long-covid/ . Accessed 12 Jan 2024</Citation></Reference><Reference><Citation>Joshi D, Manohar S, Goel G, Saigal S, Pakhare AP, Goyal A (2021) Adequate antithrombin III level predicts survival in severe COVID-19 pneumonia. Cureus 13(10):e18538. https://doi.org/10.7759/cureus.18538</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18538</ArticleId><ArticleId IdType="pubmed">34754684</ArticleId><ArticleId IdType="pmc">8570439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E (2022) A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J 479(4):537&#x2013;559. https://doi.org/10.1042/BCJ20220016</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinaneh S, Khamaysi I, Karram T, Hamoud S (2021) Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy. Biosci Rep. https://doi.org/10.1042/BSR20210290</Citation></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G (2022) Long COVID and its management. Int J Biol Sci 18(12):4768&#x2013;4780. https://doi.org/10.7150/ijbs.75056</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId><ArticleId IdType="pmc">9305273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Aktay-Cetin &#xd6;, Craddock V, Morales-Cano D, Kosanovic D, Cogolludo A, Perez-Vizcaino F, Avdeev S, Kumar A, Ram AK, Agarwal S, Chakraborty A, Savai R, de Jesus Perez V, Graham BB, Butrous G, Dhillon NK (2023) Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: multilayered cross-talks in the setting of coinfections and comorbidities. PLoS Pathog 19(1):e1011063. https://doi.org/10.1371/journal.ppat.1011063</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011063</ArticleId><ArticleId IdType="pubmed">36634048</ArticleId><ArticleId IdType="pmc">9836319</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Hsu CK, Yen MY, Lee PI, Ko WC, Hsueh PR (2023a) Long COVID: an inevitable sequela of SARS-CoV-2 infection. J Microbiol Immunol Infect = Wei Mian Yu Gan Ran Za Zhi 56(1):1&#x2013;9. https://doi.org/10.1016/j.jmii.2022.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType="pubmed">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D (2023b) Biomarkers in long COVID-19: a systematic review. Front Med 10:1085988. https://doi.org/10.3389/fmed.2023.1085988</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId></ArticleIdList></Reference><Reference><Citation>Larionova R, Byvaltsev K, Kravtsova O, Takha E, Petrov S, Kazarian G, Valeeva A, Shuralev E, Mukminov M, Renaudineau Y, Arleevskaya M (2022) SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases. J Transl Autoimmun 5:100154. https://doi.org/10.1016/j.jtauto.2022.100154</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2022.100154</ArticleId><ArticleId IdType="pubmed">35434592</ArticleId><ArticleId IdType="pmc">9005220</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemogne C, Gouraud C, Pitron V, Ranque B (2023) Why the hypothesis of psychological mechanisms in long COVID is worth considering. J Psychosom Res 165:111135. https://doi.org/10.1016/j.jpsychores.2022.111135</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2022.111135</ArticleId><ArticleId IdType="pubmed">36623391</ArticleId><ArticleId IdType="pmc">9825049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EHT, van Amstel RBE, de Boer VV, van Vught LA, de Bruin S, Brouwer MC, Vlaar APJ, van de Beek D (2023) Complement activation in COVID-19 and targeted therapeutic options: a scoping review. Blood Rev 57:100995. https://doi.org/10.1016/j.blre.2022.100995</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2022.100995</ArticleId><ArticleId IdType="pubmed">35934552</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A (2023) A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med 10:1011936. https://doi.org/10.3389/fmed.2023.1011936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId></ArticleIdList></Reference><Reference><Citation>McConnell I, Hurd CM (1976) Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells. Immunology 30(6):825&#x2013;833</Citation><ArticleIdList><ArticleId IdType="pubmed">800392</ArticleId><ArticleId IdType="pmc">1445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24:168&#x2013;175. https://doi.org/10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, Puhan MA (2021) Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS ONE 16(7):e0254523. https://doi.org/10.1371/journal.pone.0254523</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId><ArticleId IdType="pmc">8274847</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Fauci AS (2020) Emerging pandemic diseases: how we got to COVID-19. Cell 182(5):1077&#x2013;1092. https://doi.org/10.1016/j.cell.2020.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.021</ArticleId><ArticleId IdType="pubmed">32846157</ArticleId><ArticleId IdType="pmc">7428724</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafi MB, Javanmard SH (2023) Post-COVID-19 syndrome mechanisms, prevention and management. Int J Prev Med 14:59. https://doi.org/10.4103/ijpvm.ijpvm_508_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijpvm.ijpvm_508_21</ArticleId><ArticleId IdType="pubmed">37351054</ArticleId><ArticleId IdType="pmc">10284243</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystr&#xf6;m S, Hammarstr&#xf6;m P (2022) Amyloidogenesis of SARS-CoV-2 spike protein. J Am Chem Soc 144(20):8945&#x2013;8950. https://doi.org/10.1021/jacs.2c03925</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.2c03925</ArticleId><ArticleId IdType="pubmed">35579205</ArticleId><ArticleId IdType="pmc">9136918</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, Kreisle RA, Shi Y (1999) Expression of endothelial cell IgG Fc receptors and markers on various cultures. Chin Med J 112(2):157&#x2013;161</Citation><ArticleIdList><ArticleId IdType="pubmed">11593585</ArticleId></ArticleIdList></Reference><Reference><Citation>Panackal AA, Rosen LB, Uzel G, Davis MJ, Hu G, Adeyemo A, Tekola-Ayele F, Lisco A, Diachok C, Kim JD, Shaw D, Sereti I, Stoddard J, Niemela J, Rosenzweig SD, Bennett JE, Williamson PR (2017) Susceptibility to cryptococcal meningoencephalitis associated with idiopathic CD4+&#xa0;lymphopenia and secondary germline or acquired defects. Open Forum Infect Dis. https://doi.org/10.1093/ofid/ofx082</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofx082</ArticleId><ArticleId IdType="pubmed">28638843</ArticleId><ArticleId IdType="pmc">5461987</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D, Mandal G, Chukwueke L, Woods K (2022) A rare case of COVID-19-induced chronic demyelinating polyneuropathy. Cureus 14(5):e25165. https://doi.org/10.7759/cureus.25165</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.25165</ArticleId><ArticleId IdType="pubmed">35733465</ArticleId><ArticleId IdType="pmc">9205456</ArticleId></ArticleIdList></Reference><Reference><Citation>Priemer DS, Rhodes CH, Karlovich E, Perl DP, Goldman JE (2022) A&#x3b2; deposits in the neocortex of adult and infant hypoxic brains, including in cases of COVID-19. J Neuropathol Exp Neurol 81(12):988&#x2013;995. https://doi.org/10.1093/jnen/nlac095</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlac095</ArticleId><ArticleId IdType="pubmed">36264253</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB (2021) Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 12:698169. https://doi.org/10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId><ArticleId IdType="pmc">8260991</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimmanesh I, Kouhpayeh S, Azizi Y, Khanahmad H (2022) Conceptual framework for SARS-CoV-2-related lymphopenia. Adv Biomed Res 11:16. https://doi.org/10.4103/abr.abr_303_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/abr.abr_303_20</ArticleId><ArticleId IdType="pubmed">35386537</ArticleId><ArticleId IdType="pmc">8977610</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando HM, Bennett TD, Byrd JB, Bramante C, Callahan TJ, Chute CG, Davis HE, Deer R, Gagnier J, Koraishy FM, Liu F, McMurry JA, Moffitt RA, Pfaff ER, Reese JT, Relevo R, Robinson PN, Saltz JH, Solomonides A, Sule A, Haendel MA (2021) Challenges in defining long COVID: striking differences across literature, electronic health records, and patient-reported information. medRxiv. https://doi.org/10.1101/2021.03.20.21253896</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId><ArticleId IdType="pubmed">33791733</ArticleId><ArticleId IdType="pmc">8010765</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, Oude Egbrink MG (2007) The endothelial glycocalyx: composition, functions, and visualization. Pflugers Archiv: Eur J Physiol 454(3):345&#x2013;359. https://doi.org/10.1007/s00424-007-0212-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-007-0212-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezkalla SH, Kloner RA (2021) Post-acute sequelae of SARS-COVID-2 syndrome: just the beginning. Cardiol Res 12(5):279&#x2013;285</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/cr1290</ArticleId><ArticleId IdType="pubmed">34691325</ArticleId><ArticleId IdType="pmc">8510656</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Herr&#xe1;n M, Ram&#xed;rez-Santana C, Leung PSC, Anaya JM, Ridgway WM, Gershwin ME (2023) Molecular mimicry and autoimmunity in the time of COVID-19. J Autoimmun 139:103070. https://doi.org/10.1016/j.jaut.2023.103070</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2023.103070</ArticleId><ArticleId IdType="pubmed">37390745</ArticleId><ArticleId IdType="pmc">10258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Sant&#x2019;Anna FM, Resende RCL, Sant&#x2019;Anna LB, Couceiro SLM, Pinto RBS, Sant&#x2019;Anna MB, Chao LW, Szeles JC, Kaniusas E (2023) Auricular vagus nerve stimulation: a new option to treat inflammation in COVID-19? Rev Assoc Med Bras. https://doi.org/10.1590/1806-9282.20230345</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.20230345</ArticleId><ArticleId IdType="pubmed">37909531</ArticleId><ArticleId IdType="pmc">10241082</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin DD (2023) Is long COVID an autoimmune disease? Eur Respir J 61(1):2202272. https://doi.org/10.1183/13993003.02272-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02272-2022</ArticleId><ArticleId IdType="pubmed">36634924</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanich X, Rigo-Bonnin R, Gumucio VD, Bastard P, Rosain J, Philippot Q, Perez-Fernandez XL, Fuset-Cabanes MP, Gordillo-Benitez M&#xc1;, Suarez-Cuartin G, Boza-Hernandez E, Riera-Mestre A, Parra-Mart&#xed;nez A, Colobran R, Antol&#xed; A, Navarro S, Rocamora-Blanch G, Framil M, Calatayud L, Corbella X, Sabater-Riera J (2021) Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of covid-19 patients admitted to intensive care in barcelona. J Clin Immunol 41(8):1733&#x2013;1744. https://doi.org/10.1007/s10875-021-01136-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01136-x</ArticleId><ArticleId IdType="pubmed">34570326</ArticleId><ArticleId IdType="pmc">8475877</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, Zhang K, Patel Z, Salter B, Yuen ACY, Lau KS, Cowbrough B, Radford K, Huang C, Kjarsgaard M, Dvorkin-Gheva A, Smith J, Li QZ, Waserman S, Ryerson CJ, Mukherjee M (2023) Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J 61(1):2200970. https://doi.org/10.1183/13993003.00970-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, Winkler CW, Sun J, Dickey JM, Ylaya K, Ko SH, Platt AP, Burbelo PD, Quezado M, Pittaluga S, Purcell M, Munster VJ, Belinky F, Ramos-Benitez MJ, Boritz EA, Chertow DS (2022) SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612(7941):758&#x2013;763. https://doi.org/10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId><ArticleId IdType="pmc">9749650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumantri S, Rengganis I (2023) Immunological dysfunction and mast cell activation syndrome in long COVID. Asia Pac Allergy 13(1):50&#x2013;53. https://doi.org/10.5415/apallergy.0000000000000022</Citation><ArticleIdList><ArticleId IdType="doi">10.5415/apallergy.0000000000000022</ArticleId><ArticleId IdType="pubmed">37389095</ArticleId><ArticleId IdType="pmc">10166245</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobler DL, Pruzansky AJ, Naderi S, Ambrosy AP, Slade JJ (2022) Long-Term cardiovascular effects of covid-19: emerging data relevant to the cardiovascular clinician. Curr Atheroscler Rep 24(7):563&#x2013;570. https://doi.org/10.1007/s11883-022-01032-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-022-01032-8</ArticleId><ArticleId IdType="pubmed">35507278</ArticleId><ArticleId IdType="pmc">9065238</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E (2023) Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab 34(6):321&#x2013;344. https://doi.org/10.1016/j.tem.2023.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId><ArticleId IdType="pmc">10113134</ArticleId></ArticleIdList></Reference><Reference><Citation>Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ (2019) Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis. Curr Drug Targets 20(16):1695&#x2013;1701. https://doi.org/10.2174/1389450120666190715102510</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450120666190715102510</ArticleId><ArticleId IdType="pubmed">31309890</ArticleId><ArticleId IdType="pmc">7696651</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedicinals-9 (2020) A German-Indian Biotech Company. A clinical trial to evaluate the effectiveness and safety of vedicinals-9-a herbal formulation in mild to moderate COVID-19 patients. https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/ictrp-CTRI202010028364 . Accessed 15 Jan 2024</Citation></Reference><Reference><Citation>Walker UA, Warnatz K (2006) Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 18(4):389&#x2013;395. https://doi.org/10.1097/01.bor.0000231908.57913.2f</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.bor.0000231908.57913.2f</ArticleId><ArticleId IdType="pubmed">16763460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, H&#xf6;nicke AS, M&#xfc;ller J (2021) Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun 4:100100. https://doi.org/10.1016/j.jtauto.2021.100100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId><ArticleId IdType="pmc">8049853</ArticleId></ArticleIdList></Reference><Reference><Citation>Whyte CS, Simpson M, Morrow GB, Wallace CA, Mentzer AJ, Knight JC, Shapiro S, Curry N, Bagot CN, Watson H, Cooper JG, Mutch NJ (2022) The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1. J Thromb Haemos: JTH 20(10):2394&#x2013;2406. https://doi.org/10.1111/jth.15806</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylikoski J, Markkanen M, M&#xe4;kitie A (2020) Pathophysiology of the COVID-19 - entry to the CNS through the nose. Acta Otolaryngol 140(10):886&#x2013;889. https://doi.org/10.1080/00016489.2020.1773533</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016489.2020.1773533</ArticleId><ArticleId IdType="pubmed">32597276</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Wang M, Zhang X, Li S, Lu Q, Zeng H, Hou H, Li H, Zhang M, Jiang F, Wu J, Ding R, Zhou Z, Liu M, Si W, Zhu T, Li H, Ma J, Gu Y, She G, Wang Y (2021) Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients. Signal Transduct Target Ther 6(1):346. https://doi.org/10.1038/s41392-021-00759-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00759-1</ArticleId><ArticleId IdType="pubmed">34561414</ArticleId><ArticleId IdType="pmc">8463587</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Zhang J, Wang C, Chen X, Zhao X, Jing H, Liu H, Li Z, Wang L, Shi J (2021) COVID-19 and ischemic stroke: mechanisms of hypercoagulability (Review). Int J Mol Med 47(3):21. https://doi.org/10.3892/ijmm.2021.4854</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2021.4854</ArticleId><ArticleId IdType="pubmed">33448315</ArticleId><ArticleId IdType="pmc">7849983</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Deng Y, Zhao Z, Mao B, Lu M, Lin Y, Huang A (2022) Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects. Cell Mol Immunol 19(2):150&#x2013;157. https://doi.org/10.1038/s41423-021-00774-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00774-w</ArticleId><ArticleId IdType="pubmed">34645940</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R&#xf6;ssler A, Kimpel J, Adolph TE, Tilg H (2022) Postacute COVID-19 is characterized by Gut viral antigen persistence in inflammatory bowel DISEASES. Gastroenterology 163(2):495-506.e8. https://doi.org/10.1053/j.gastro.2022.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J (2020) SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 382(12):1177&#x2013;1179. https://doi.org/10.1056/NEJMc2001737</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001737</ArticleId><ArticleId IdType="pubmed">32074444</ArticleId><ArticleId IdType="pmc">7121626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuniga M, Gomes C, Carsons SE, Bender MT, Cotzia P, Miao QR, Lee DC, Rodriguez A (2021) Autoimmunity to annexin A2 predicts mortality among hospitalised COVID-19 patients. Eur Respir J 58(4):2100918. https://doi.org/10.1183/13993003.00918-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00918-2021</ArticleId><ArticleId IdType="pubmed">34244321</ArticleId><ArticleId IdType="pmc">8859972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>